Loading...
Tumor plasma flow determined by dynamic contrast-enhanced MRI predicts response to induction chemotherapy in head and neck cancer.
Bernstein, Jonathan M Kershaw, Lucy E Withey, Stephanie B Lowe, Natalie M Homer, Jarrod J Slevin, Nicholas J Bonington, Suzanne C Carrington, Bernadette M West, Catharine M L
Bernstein, Jonathan M
Kershaw, Lucy E
Withey, Stephanie B
Lowe, Natalie M
Homer, Jarrod J
Slevin, Nicholas J
Bonington, Suzanne C
Carrington, Bernadette M
West, Catharine M L
Citations
Altmetric:
Abstract
Non-response to induction chemotherapy (IC) occurs in 30% of head and neck squamous cell carcinoma (HNSCC) and has been predicted by tumor plasma flow (Fp) derived by perfusion computed tomography. The present study was designed to test whether baseline tumor Fp determined by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) would predict IC response.
Description
Date
2015-02-17
Publisher
Collections
Keywords
Type
Article
Citation
Tumor plasma flow determined by dynamic contrast-enhanced MRI predicts response to induction chemotherapy in head and neck cancer. 2015: Oral Oncol